60 seconds with ICON: Adaptive Designs in Clinical Trials this April

Share Article

SMi Group 8th annual Adaptive Designs in Clinical Trials Conference will be returning to London on 18-19 April 2016

Adaptive Designs in Clinical Trials

Bringing technological advances to patients in the most efficient manner

SMi Group 8th annual Adaptive Designs in Clinical Trials Conference will be returning to London on 18-19 April 2016.

In the run up of the event, SMi Group have caught up with Silke Jorgens from ICON for a 60 seconds interview about critical challenges on adaptive designs in clinical trials.

“Adaptive design of clinical trial has been around for 20 years, and practitioners have built on experience and improved modelling techniques. However, there are still a number of challenges especially with implementation and patient recruitment. There is often a mismatch between actual clinical trial duration and project planning. I believe the industry has to overcome this via the use of early readouts for interim decision making to mitigate any limitation of adaptive design of clinical trial to ensure smooth and optimal operation”

The interview will cover Silke’s current role; challenges in the field; adaptive design implementation; strategies for clinical development of rare diseases; new developments for 2016 and much more.
For a full version of the interview please visit http://www.adaptivedesigns.co.uk/pweb

Silke Jorgens will be presenting at the conference on “Software solutions for exploratory and confirmatory trials’’:

  • ADDPLAN BASE/MC/PE for confirmatory trials, including comparisons of multiple treatments against control and subgroup selection at interim analyses
  • ADDPLAN DF for exploratory trials, including dose escalation methods and MCPMod
  • Future plans

Returning for its 8th year, the Adaptive Designs in Clinical Trials event will highlight an array of topics, including adaptive designs within the context of a development programme, Bayesian analysis in adaptive design, biomarker-driven trials, regulatory issues, and more.

Other key speakers include:

  • Fredrik Ohrn Statistical Science Director, AstraZeneca
  • Loic Darchy, Head of Statistical Methodology Group, Sanofi R&D
  • Alex Sverdlov, Associate Director of Biostatistics, EDM Serono
  • Bo Huang, Director of Biostatistics, Pfizer USA
  • Philip Hougaard, Vice President, Biometrics, Lundbeck A/S
  • Giacomo Mordenti, Senior Director, Head of Biostatistics, Grunenthal
  • Frank Fleischer, Team Leader Clinical Biostatistics, Boehringer-Ingelheim

For sponsorship registrations: Contact Andrew Gibbons at +44 (0) 20 7827 6156 or email: agibbons(at)smi-online(dot)co.uk
For delegate registrations: Contact Matthew Apps on +44 (0) 20 7827 6093 or email: mapps(at)smi-online(dot)co.uk
8th annual Adaptive Designs in Clinical Trials conference and exhibition
18th – 19th April 2016
London, UK
Contact e-mail: aserazetdinova(at)smi-online(dot)co.uk
Contact number: +44 (0) 20 7827 6093
Event Website: http://www.adaptivedesigns.co.uk/pweb

------------------------- END --------------------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anna Serazetdinova
SMi Group
+44 2078276088
Email >
Follow >
Zoe Gale

Visit website